Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)
Launched by H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE · Aug 18, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The STRONG-PCS trial is studying a program designed to support people with pancreatic cancer after they have surgery. This program offers extra help from dietitians to improve nutrition and overall well-being for patients as they recover. The goal is to see how well the program works and how satisfied participants feel about the support they receive.
To participate in this trial, you need to be at least 18 years old and have been diagnosed with pancreatic cancer. You must have undergone a specific type of surgery at Moffitt Cancer Center and be able to eat solid food afterward. Additionally, you should be able to understand either English or Spanish and give your permission to join the study. If you meet these criteria, you can expect to receive personalized nutrition guidance and support tailored to your needs as you heal. This trial is currently looking for participants, so if you or a loved one is interested, you might be a good fit!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥18 years old
- • Diagnosis of pancreatic cancer
- • Completed open pancreatic surgery (e.g., Whipple, distal/subtotal pancreatectomy, total pancreatectomy) for treatment at Moffitt Cancer Center
- • Discharged on an oral diet
- • Able to speak and read English or Spanish
- • Able to provide informed consent
- Exclusion Criteria:
- • Determined to be ineligible for surgery during evaluation (e.g., cancer metastasis)
About H. Lee Moffitt Cancer Center And Research Institute
H. Lee Moffitt Cancer Center and Research Institute is a leading institution dedicated to cancer research, treatment, and education, recognized for its commitment to advancing cancer care through innovative clinical trials and groundbreaking research. As a National Cancer Institute-designated Comprehensive Cancer Center, Moffitt integrates cutting-edge science with patient-centered care, offering a multidisciplinary approach to cancer treatment. The center is at the forefront of developing novel therapies and improving outcomes for patients, emphasizing collaboration between researchers and clinicians to translate scientific discoveries into effective treatments. Through its extensive clinical trial programs, Moffitt aims to enhance the understanding of cancer biology and provide patients with access to the latest therapies and interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tampa, Florida, United States
Patients applied
Trial Officials
Kea Turner, PhD
Principal Investigator
Moffitt Cancer Center
Pamela J Hodul, MD
Principal Investigator
Moffitt Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported